Working... Menu

Oral Immunotherapy for Peanut and Mammalian Meat Allergies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02350660
Recruitment Status : Completed
First Posted : January 30, 2015
Last Update Posted : December 16, 2015
Information provided by (Responsible Party):
Scott Commins, MD, University of Virginia

Brief Summary:
Pilot study to assess the effect of oral immunotherapy on specific IgE levels and antigen consumption in two distinct food allergies.

Condition or disease Intervention/treatment Phase
Food Hypersensitivity Dietary Supplement: cow's milk Dietary Supplement: peanut powder Not Applicable

Detailed Description:
In subjects with mammalian meat allergy, the effect of daily oral cow's milk on immune parameters and desensitization will be assessed. Similarly, in subjects with a peanut allergy the effects of low dose peanut flour will be assessed and comparisons between two distinct food allergies.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 23 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Oral Immunotherapy for Peanut and Mammalian Meat Allergies
Study Start Date : March 2012
Actual Primary Completion Date : September 2014
Actual Study Completion Date : June 2015

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Cow's milk for alpha-gal allergics
daily consumption of cow's milk
Dietary Supplement: cow's milk
daily consumption of cow's milk

Experimental: Peanut powder
peanut oral immunotherapy
Dietary Supplement: peanut powder
peanut oral immunotherapy

Primary Outcome Measures :
  1. The level of allergen specific IgE present pre- and post-oral immunotherapy [ Time Frame: Participants will be followed for the duration of maintenance oral immunotherapy, an expected average of 36 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   4 Years to 80 Years   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Presence or absence of specific IgE to alpha-gal or peanut

Exclusion Criteria:

  • History of severe anaphylaxis
  • allergy to cow's milk protein

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02350660

Layout table for location information
United States, Virginia
University of Virginia
Charlottesville, Virginia, United States, 22908
Sponsors and Collaborators
University of Virginia
Layout table for investigator information
Principal Investigator: Scott Commins, MD University of Virginia

Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Scott Commins, MD, Associate Professor, Department of Medicine, Allergy and Immunology, University of Virginia Identifier: NCT02350660     History of Changes
Other Study ID Numbers: 15098
First Posted: January 30, 2015    Key Record Dates
Last Update Posted: December 16, 2015
Last Verified: December 2015

Additional relevant MeSH terms:
Layout table for MeSH terms
Food Hypersensitivity
Immune System Diseases
Hypersensitivity, Immediate
Immunologic Factors
Physiological Effects of Drugs